Facebook Linkedin RSS Twitter Youtube
Home 2022

Human cytomegalovirus

Gene Therapy Turns to the Use of Synthetic Biology Principles
Bioprocessing

Gene Therapy Turns to the Use of Synthetic Biology Principles

John Sterling -
0
Immune Surrogate Finding May Accelerate CMV Vaccine Development
Drug Discovery

Immune Surrogate Finding May Accelerate CMV Vaccine Development

John Sterling -
0
Cytomegalovirus’ Immune Evasion Tactics Uncovered
Featured

Cytomegalovirus’ Immune Evasion Tactics Uncovered

Jeffrey S. Buguliskis, Ph.D. -
0
mRNA-Based Drugs Prepare to Go the Distance
Drug Discovery

mRNA-Based Drugs Prepare to Go the Distance

Kathy Liszewski -
0
Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines
Drug Discovery

Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines

GEN Staff Writer -
0
Brain Cancer Vaccine–Chemotherapy Combo Shows Promise
Cancer

Brain Cancer Vaccine–Chemotherapy Combo Shows Promise

GEN Staff Writer -
0
Positive Phase III Data for Merck Candidates against CMV and Shingles
Drug Discovery

Positive Phase III Data for Merck Candidates against CMV and Shingles

GEN Staff Writer -
0
Chimerix Axes 20% of Workforce, Citing Phase III Failure
Drug Discovery

Chimerix Axes 20% of Workforce, Citing Phase III Failure

GEN Staff Writer -
0
Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial
Drug Discovery

Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial

GEN Staff Writer -
0
Chimerix Names New CEO, a Month after Compassionate Use Flap
News

Chimerix Names New CEO, a Month after Compassionate Use Flap

GEN Staff Writer -
0
1234Page 1 of 4
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.